Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn:
“Honored to contribute to the JSMO 2025 Plenary Session with a talk on ADCs/immunotherapy combinations, and to join brilliant panel discussions with Shanu Modi, Junji Tsurutani, Aleix Prat, Sung Bae Kim and Ayumi Saito.
Always derive terrific insights on the present and future of ADCs in Japan.
Thanks to the JSMO Committee for having us!”